头颈癌放化疗后患者报告的吞咽结局与生理性吞咽结局的对比
回顾性纳入30例接受放化疗后行电视透视吞咽检查的头颈癌患者,同期完成MD Anderson吞咽困难量表(MDADI),用DIGEST量表评估安全性和效率。MDADI与DIGEST各评分均无相关性;随时间推移MDADI无显著变化,而DIGEST评分变差,提示患者对吞咽功能障碍的自我感知不足。
要点
- MDADI与DIGEST-E、DIGEST-S及DIGEST总分均无相关性。
- 随放疗后时间延长,MDADI评分无显著变化,而DIGEST评分变差。
- 患者对放化疗后数年吞咽功能下降的自我感知可能不足。
核心结论
- 吞咽生理评估显示放化疗后功能变差,但未与患者报告的生活质量指标相关。
- 放化疗结束数年患者对吞咽功能障碍的感知降低,对生理功能下降时的吞咽困难管理有启示。
研究设计与样本
- 回顾性研究,纳入接受放化疗且行电视透视吞咽检查的成人头颈癌患者,排除手术治疗者,共30例符合纳入标准。
- 患者在同一天完成MDADI和电视透视吞咽检查,用DIGEST量表评估安全性(DIGEST-S:渗透/误吸)和效率(DIGEST-E:残留),行相关系数统计分析。
主要发现
- 口咽是最常见受累部位(70.0%),其次为喉(16.7%)。
- 中位放疗剂量为72戈瑞(Gy),评估时间为治疗完成后平均4.6年(范围0-12年)。
- MDADI与DIGEST-E评分无相关性(Pearson rho = -0.045,P = 0.812),与DIGEST-S评分无相关性(Pearson rho = 0.075,P = 0.695),与DIGEST总分无相关性(Pearson rho = 0.046,P = 0.810)。
- MDADI评分随放疗后时间延长无显著变化(P = 0.375),而DIGEST-E评分、DIGEST-S评分和DIGEST总分随时间变差(P = 0.007、P = 0.002、P = 0.0005)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The primary objective of this project was to retrospectively investigate the relationship between patient-reported and physiologic swallowing measures after chemoradiation therapy for head neck cancer (HNC). METHODS: Adult patients who underwent chemoradiation therapy for HNC and presented for videofluoroscopic swallow study were reviewed retrospectively. Surgically treated patients were excluded. Patient perception of swallowing-related outcomes was assessed via the MD Anderson Dysphagia Inventory (MDADI) on the same day that physiologic measures of swallow function were obtained. Using vidoefluoroscopic data, the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) scale yielded measures of safety (DIGEST-S: penetration/aspiration) and efficiency (DIGEST-E: residue). Statistical analysis for correlation coefficients was performed. RESULTS: Thirty patients met the inclusion criteria. The oropharynx was the most commonly affected site (70.0%), followed by the larynx (16.7%). The median radiation dose was 72 grays (Gy), and participants were assessed a mean of 4.6 (range 0-12) years following completion of treatment. There was no correlation between the MDADI and the DIGEST-E score (Pearson rho = -0.045, P = 0.812), DIGEST-S score (Pearson rho = 0.075, P = 0.695), or summary DIGEST grade (Pearson rho = 0.046, P = 0.810). MDADI scores did not change significantly with increasing time since radiation (P = 0.375), whereas the DIGEST-E scores, DIGEST-S score, and summary DIGEST grades worsened over time (P = 0.007, P = 0.002, and P = 0.0005, respectively). CONCLUSION: Assessment of swallowing physiology showed that function worsened after chemoradiation therapy, but this did not correlate with patient-reported quality-of-life measures. Reduced patient awareness of swallow dysfunction years after completion of chemoradiation has implications for management of dysphagia in the face of physiologic decline. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:2059-2064, 2019.
引用
- Kirsh E, Naunheim M, Holman A, et al. Patient-reported versus physiologic swallowing outcomes in patients with head and neck cancer after chemoradiation. Laryngoscope. 2018. PMID: 30582151. doi:10.1002/lary.27610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。